Gibson, Dunn & Crutcher LLP advised Merck on its acquisition of Caraway Therapeutics, Inc. Merck (NYSE: MRK), known as MSD outside of the United States and...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP served as legal advisor to the Partnership and Lazard acted as financial advisor to the Partnership. On November 21, 2023, USD...
You must be a Standard 1 Year member to access this content.
Brown?Forman’s financial advisor was Greenhill & Co., LLC and its legal advisors were Gibson, Dunn & Crutcher LLP and Coblentz Patch Duffy & Bass LLP. Brown-Forman...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is assisting the Conflicts Committee of the Board of Directors of Hess Midstream LP on the repurchase. Hess Midstream LP (NYSE:...
You must be a Standard 1 Year member to access this content.
KippsDeSanto & Co. served as exclusive financial advisors and Sparks Willson, P.C. as legal counsel to Outside Analytics. Gibson, Dunn & Crutcher, LLP served as legal...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn and Crutcher LLP provided legal counsel to WPG and Strategic Value Partners. Cleary Gottlieb Steen & Hamilton LLP served as legal counsel to the...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised Royalty Pharma in connection with its development funding. Royalty Pharma plc (Nasdaq: RPRX) and Teva Pharmaceuticals International GmbH, a subsidiary...
You must be a Standard 1 Year member to access this content.
In the operation, Wise Equity SGR and Fi.Mo.Tec are supported by Benesch, Simmons & Simmons and PwC; Wanho is assisted by Gibson Dunn; financial institutions are...
You must be a Standard 1 Year member to access this content.
Raymond James acted as exclusive financial advisor to the Special Committee. Stifel Canada acted as independent valuator to the Special Committee. Osler, Hoskin & Harcourt LLP...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is advising Calumet Specialty Products Partners, L.P. on the transaction. Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) announced the execution of an...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP represented Welltower Inc. in the offering. Welltower Inc. (NYSE: WELL) priced the public offering for the 17,500,000 shares of its common stock...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised MidOcean Partners on its acquisition of Smith System Driver Improvement Institute, Inc., while Kirkland & Ellis advised Levine Leichtman Capital...
You must be a Standard 1 Year member to access this content.
